NCT02142634View on ClinicalTrials.gov

Budesonide for Induction of Remission in Incomplete Microscopic Colitis

PHASE3CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

February 29, 2020

Study Completion Date

February 29, 2020

Conditions
Incomplete Microscopic Colitis
Interventions
DRUG

Budesonide granules 9 mg

per day

DRUG

Placebo granules

per day

Trial Locations (2)

20249

Centre for Digestive Diseases, Hamburg

58185

University Hospital of Linköping, Dept. of Gastroenterology and Hepatology, Linköping

Sponsors
All Listed Sponsors
lead

Dr. Falk Pharma GmbH

INDUSTRY